RNF6 and retinoblastoma: To check whether RNF6 induced carboplatin resistance in RB cells through certain signaling pathways, Y-79/CR cells were first treated with a panel of specific inhibitors targeting common drug resistance pathways and then the cell sensitivity to carboplatin was assessed.